Ocular Toxicities & Management of Other Adverse Events with ADC's-Presentation Recording

Video Transcription

Video Summary

The video transcript is a recording of a webinar titled "Ocular Toxicity and Management of Other Adverse Events with ADCs or Antibody Drug Conjugates." The speakers are Dr. Gottfried Konechny and Dr. Mark Slava. The webinar is part of the IGCS Education Advances and Updates Workgroup and is sponsored by Immunogen and CGen. The purpose of the webinar is to provide education on the ocular toxicity and management of adverse events associated with ADCs in gynecologic oncology. The speakers discuss the mechanism of action of ADCs and the different toxicities associated with specific drugs, such as conjunctivitis, keratopathy, and blurred vision. They also discuss the use of mitigation strategies, including cold packs, vasoconstrictor eye drops, lubricant drops, and topical steroids. The speakers emphasize the importance of regular monitoring of patients' ocular symptoms and eye health, as well as the need for communication and collaboration with eye care providers to ensure the safe and effective use of ADCs. They highlight the overall low toxicity and high efficacy of ADCs and the need to counsel patients about the manageable nature of ocular toxicities. The webinar provides valuable information for healthcare professionals involved in the treatment of gynecologic oncology patients receiving ADCs.

Keywords

ocular toxicity

ADCs

gynecologic oncology

mechanism of action

conjunctivitis

keratopathy

blurred vision

mitigation strategies

monitoring

healthcare professionals